Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout
Public ClinicalTrials.gov record NCT01356498. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Open Label Extension Study of 8 mg PEG-uricase in Subjects Who Completed Protocols C0405 or C0406 for Symptomatic Gout
Study identification
- NCT ID
- NCT01356498
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Savient Pharmaceuticals
- Industry
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Interventions
- pegloticase Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2006
- Primary completion
- Dec 31, 2009
- Completion
- Dec 31, 2009
- Last update posted
- Dec 1, 2011
2006 – 2010
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente Medical Center, Clinical Trials Unit | San Francisco | California | 94118 | — |
| Pacific Arthritis Center Medical Group | Santa Maria | California | 93454 | — |
| Agilence Arthritis & Osteoporosis Medical Center | Whittier | California | 90606 | — |
| Veterans Affairs Medical Center | Washington D.C. | District of Columbia | 20422 | — |
| Arthritis & Rheumatic Disease Specialties | Aventura | Florida | 33180 | — |
| Ocala Rheumatology Research Center | Ocala | Florida | 34474 | — |
| St. Petersburg Arthritis Center | St. Petersburg | Florida | 33703 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Graves Gilbert Clinic | Bowling Green | Kentucky | 42101 | — |
| Peter A. Holt, M.D. | Baltimore | Maryland | 21239 | — |
| Center for Rheumatology and Bone Research | Wheaton | Maryland | 20902 | — |
| Justus J. Fiechtner, MD, PC | Lansing | Michigan | 48910 | — |
| CentraCare Clinic | Saint Cloud | Minnesota | 56377 | — |
| Rheumatology Associates of North Jersey | Teaneck | New Jersey | 07666 | — |
| Duke University Medical Center | Durham | North Carolina | 27302 | — |
| New Horizons Clinical Research | Cincinnati | Ohio | 45242 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| STAT Research, Inc. | Dayton | Ohio | 45402 | — |
| David R. Mandel, MD, Inc. | Mayfield Village | Ohio | 44143 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Mid Atlantic Research Assoc. | Philadelphia | Pennsylvania | 19154 | — |
| Arthritis Northwest, PLLC | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01356498, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2011 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01356498 live on ClinicalTrials.gov.